Pulmatrix (PULM) Intangibles (2015 - 2016)
Pulmatrix (PULM) posted Intangibles of $7.5 million for Q3 2016, little changed sequentially from $7.5 million in Q1 2016, and little changed YoY from $7.5 million in Q4 2015.
Pulmatrix (PULM) Intangibles (2015 - 2016) Analysis & Trends
Pulmatrix has reported Intangibles for 2 years, with the latest figure at $7.5 million in Q3 2016.
- Quarterly Intangibles changed 0.0% year-over-year to $7.5 million in Q3 2016, while the trailing twelve-month figure through Sep 2016 was $7.5 million (changed 0.0% YoY) and the FY2015 annual result came in at $7.5 million, changed N/A from the prior year.
- Intangibles held at $7.5 million in Q3 2016 per PULM's latest filing, from $7.5 million in the prior quarter.
- Over five years, Intangibles peaked at $7.5 million in Q2 2015 and troughed at $7.5 million in Q2 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 266.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 60.96 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 93.49 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Pulmatrix | 5.46 Mn | 5.46 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2016 | 7.53 Mn |
| Mar 31, 2016 | 7.53 Mn |
| Dec 31, 2015 | 7.53 Mn |
| Sep 30, 2015 | 7.53 Mn |
| Jun 30, 2015 | 7.53 Mn |